Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Plus, a massive $2 billion investment in new production facilities!
Shipping now! Patients must decide between data on the phone or pump.
Marks the largest ever one-time research investment from the AHA – how Google is planning to “shake it up.”
Major organizations make it clear: diabetes education is critical!
Launch before the second half of 2016. What savings program will be offered?
How you can tell drug and device makers what YOU want from diabetes products.
What does this controversial data mean for the type 2 diabetes epidemic?
New blinded sensor worn for 14 days that will give a detailed picture of your glucose levels.
My reflections on a visionary, scientist, role model, and friend.
Plus, exciting details on Google’s glucose-sensing contact lens!
Plus, my Resolutions for 2016!
Yesterday, Sanofi announced a partnership with Google Life Sciences to improve diabetes care through new sensors, wearable devices, and better software. The partnership...
Diagnoses stabilizing, though 83% of 65+ year olds have diabetes or prediabetes.
Our top takeaways from the health and medicine edition of the world-famous TED conference.
The 338-patient, Dexcom-sponsored DIaMonD Study aims to find out.
A new study from Dr. Doug Melton’s team provides hope for the future of stem cell treatment in diabetes. But there’s still a long way to go.
How a culture of stigma and shame is hurting the conversation about diabetes.
New trial aims to make U500 (more concentrated) insulin easier to take.
Plus, a new agreement to integrate the Gen 5 and Gen 6 Dexcom CGMs.
Insights from Dr. Sean Vasaitis on what makes D.A.I.L.Y. unique.

Pages